We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
Cap. Flow
+$3M
Cap. Flow %
0.15%
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294

Top Buys

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$8.42M
2
MPC icon
Marathon Petroleum
MPC
+$5.47M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$5.39M
4
ORLY icon
O'Reilly Automotive
ORLY
+$5.32M
5
CROX icon
Crocs
CROX
+$5.07M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.6M
2
TPR icon
Tapestry
TPR
+$12M
3
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$8.32M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.96M
5
SAGE
Sage Therapeutics
SAGE
+$6.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 85.48%
2 Healthcare 3.75%
3 Consumer Discretionary 2.73%
4 Technology 1.96%
5 Energy 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LVS icon
751
Las Vegas Sands
LVS
$26.7B
– –
-80,100
Closed -$4.88M
LVS icon
752
PUT
Las Vegas Sands
LVS
$26.7B
– –
-150,000
Closed -$9.14M
LW icon
753
CALL
Lamb Weston
LW
$6.47B
– –
-10,000
Closed -$749K
LW icon
754
PUT
Lamb Weston
LW
$6.47B
– –
-10,000
Closed -$749K
MAR icon
755
PUT
Marriott International
MAR
$87.9B
– –
-50,000
Closed -$6.25M
MATX icon
756
Matsons
MATX
$7.13B
– –
-19,500
Closed -$704K
MATX icon
757
PUT
Matsons
MATX
$7.13B
– –
-65,000
Closed -$2.35M
MDGL icon
758
Madrigal Pharmaceuticals
MDGL
$12.1B
– –
-9,000
Closed -$964K
MGA icon
759
Magna International
MGA
$17B
– –
-11,200
Closed -$545K
MGNX icon
760
MacroGenics
MGNX
$257M
– –
-10,000
Closed -$172K
MITK icon
761
Mitek Systems
MITK
$811M
– –
-35,000
Closed -$428K
MLM icon
762
CALL
Martin Marietta Materials
MLM
$36B
– –
-30,000
Closed -$6.04M
MLM icon
763
Martin Marietta Materials
MLM
$36B
– –
-17,100
Closed -$3.44M
MLM icon
764
PUT
Martin Marietta Materials
MLM
$36B
– –
-30,000
Closed -$6.04M
MMSI icon
765
CALL
Merit Medical Systems
MMSI
$5.15B
– –
-41,700
Closed -$2.58M
MMSI icon
766
PUT
Merit Medical Systems
MMSI
$5.15B
– –
-40,000
Closed -$2.47M
MNRO icon
767
Monro
MNRO
$391M
– –
-10,000
Closed -$865K
CALY
768
Callaway Golf Company
CALY
$2.69B
– –
-23,750
Closed -$378K
MOS icon
769
CALL
The Mosaic Company
MOS
$8.09B
– –
-71,000
Closed -$1.94M
MOS icon
770
The Mosaic Company
MOS
$8.09B
– –
-25,000
Closed -$682K
MOS icon
771
PUT
The Mosaic Company
MOS
$8.09B
– –
-71,000
Closed -$1.94M
MRK icon
772
CALL
Merck
MRK
$355B
– –
-104,800
Closed -$8.32M
MUSA icon
773
PUT
Murphy USA
MUSA
$9.67B
– –
-50,000
Closed -$4.28M
MYGN icon
774
Myriad Genetics
MYGN
$371M
– –
-35,000
Closed -$1.16M
MYGN icon
775
PUT
Myriad Genetics
MYGN
$371M
– –
-100,000
Closed -$3.32M
29 30
31
32 33

Similar funds

AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $21.4B AUM
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return

Caption Management's Q2 2019 Portfolio in Review

As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management's Q2 2019 filing shows 395 new, 92 increased, 99 reduced and 294 closed positions. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M. The largest sale was Bristol-Myers Squibb, an estimated $12.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 85% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
  • Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
  • Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
  • Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
  • Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
  • Caption Management opened 395 new positions and closed 294 in Q2 2019.
  • Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.

Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.